Pesquisa

Edição
Título
Autores
Volume 30, Nº 3 (2023)
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E., Shinkin M., Morozova I.
PDF
(Rus)
Volume 31, Nº 1 (2024)
Polypills in the fight against cardiovascular diseases: a modern review of effectiveness
Leonova M.
PDF
(Rus)
Volume 30, Nº 14 (2023)
Bempedoic acid – a new drug in lipid-lowering therapy
Leonova M.
PDF
(Rus)
Volume 30, Nº 1/2 (2023)
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
Polyakova O., Tkachenko Y., Ostroumova O.
PDF
(Rus)
Volume 31, Nº 1 (2024)
Modern possibilities of bronchodilation therapy for patients with chronic obstructive pulmonary disease
Trofimenko I., Chernyak B.
PDF
(Rus)
Volume 29, Nº 11/12 (2022)
Hypothyroidism is an untimely diagnosed disease
Verbovoy A., Verbovaya N., Sharonova L.
PDF
(Rus)
Nº 13 (2015)
Osnovnye patogeneticheskie mekhanizmy razvitiya ishemicheskikh povrezhdeniy i vozmozhnost' ikh korrektsii u patsientov s sochetannoy serdechno-sosudistoy patologiey
Shishkova V.
PDF
(Rus)
Volume 29, Nº 4 (2022)
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
PDF
(Rus)
Volume 27, Nº 4 (2020)
The many faces of vitamin D
Verbovoy A., Dolgikh Y., Verbovaya N.
PDF
(Rus)
Nº 9 (2017)
GENDER FEATURES OF ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
Ayrapetyan M., Gordeev I., Volov N.
PDF
(Rus)
Nº 9 (2016)
EVALUATION OF FREQUENCY OF TARGET ORGAN DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION WHO APPLIED FOR AN OUTPATIENT APPOINTMENT WITH A DOCTOR FOR THE FIRST TIME
Nebieridze D., Kamyshova T., Sarycheva A.
PDF
(Rus)
Nº 13 (2015)
Polimorfizm gena eNOS: rasprostranennost' i svyaz' s zabolevaniyami
Pozdnyakov N., Khokhlov A.
PDF
(Rus)
Nº 2s (2013)
SERDEChNO-SOSUDISTYE ZABOLEVANIYa I OSTEOPOROZ
Karpova N., Rashid M., Shostak N., Kazakova T.
PDF
(Rus)
Nº 15 (2010)
NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: INFLUENCE OF FEMALE SEX
Drapkina O., Korneev O., Drapkina O., Korneeva O.
Nº 14 (2009)
Myocardial infarction and stroke in pregnancy
Sharashkina N., Novikova I., Torshkhoeva K., Tkacheva O., Scharaschkina N., Novikova I., Torschchoeva C., Tkacheva O.
Volume 28, Nº 12 (2021)
Insulin resistance - a common enemy for endocrinologists and cardiologists
Verbovoy A., Dolgikh Y.
PDF
(Rus)
Nº 9 (2017)
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
PDF
(Rus)
Nº 9 (2015)
GIPERGLIKEMIYa I OSTRYY KORONARNYY SINDROM
Martynov A., Akatova E., Nikolin O., Urlaeva I.
PDF
(Rus)
Nº 9 (2009)
Not just a prostate: problems of benign prostatic hyperplasia in elderly
Vertkin A., Rodyukova I., Galkin I., Arinina E., Vertkin A., Rodukova I., Galkin I., Arinina E.
Volume 28, Nº 5 (2021)
Role and location of increased epithelial permeability syndrome in the devel-opment of cardiovascular and bronchopulum diseases: theoretical and practical aspects of application of rebamipide
Trukhan D., Ivanova D.
PDF
(Rus)
Nº 11 (2018)
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
PDF
(Rus)
Nº 5 (2017)
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
Petunina N., Terekhova A.
PDF
(Rus)
Nº 19 (2015)
OSTEOPOROZ I ATEROSKLEROZ: ChTO OBShchEGO?
Mitroshina E., Verbovoy A.
PDF
(Rus)
Nº 5 (2015)
Adipokiny i serdechno-sosudistye zabolevaniya
Verbovoy A., Mitroshina E., Sharonova L.
PDF
(Rus)
Nº 16 (2012)
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
PDF
(Rus)
Nº 8 (2010)
Hawthorn (Crataegus): options for medical use
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Nº 8 (2009)
Disturbances of lipid metabolism in pregnancy
Tkacheva O., Galyautdinova A., Prokhorovich E., Mishina I., Torshkhoeva K., Tkacheva O., Galjautdinova A., Prochorovich E., Mishina I., Torshchoeva C.
Volume 28, Nº 3 (2021)
The relationship of cardiovascular disease with increased intestinal permeability: results from scientific and controlled clinical trials. Focus on the potential of rebamipide
Ostroumova O., Kochetkov A., Pavleeva E., Golovina O., Arablinsky N.
PDF
(Rus)
Nº 11 (2018)
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy
Galstyan G., Antsiferov M., Alekseeva Y.
PDF
(Rus)
Nº 5 (2017)
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
Sharonova L., Verbovoy A., Tsanava I.
PDF
(Rus)
Nº 17 (2015)
Gipotireoz i serdechno-sosudistye zabole vaniya
Verbovoy A., Sharonova L., Kosareva O., Dolgikh Y., Verbovaya N.
PDF
(Rus)
Nº 9 (2012)
OSOBENNOSTI LEChENIYa ARTERIAL'NOY GIPERTENZII U PATsIENTOV POZhILOGO VOZRASTA
Napalkov D., Golovenko E.
PDF
(Rus)
Nº 8 (2010)
POTENTIAL FOR USE OF DIET THERAPY FOR REDUCTION OF THE CARDIOVASCULAR RISK
Ruzhentsova T., Ruzhentsova T.
Nº 6 (2009)
Anxiety and depression as risk factors of cardiovascular diseases: possibilities of medicamentous correction
Makolkin V., Makolkin V.
Volume 27, Nº 13 (2020)
The role of the disturbances in the intestinal barrier structure in relation to cardiovascular diseases pathogenesis and rebamipid potential in their correction
Ostroumova O., Kochetkov A.
PDF
(Rus)
Nº 2 (2017)
Nonalcoholic fatty liver disease and cardiovascular risk (literature review)
Shirokova E.
PDF
(Rus)
Nº 17 (2015)
Ozhirenie kak faktor riska serdechno- sosudistykh zabolevaniy. Obzor literatury
Starodubova A., Kislyak O.
PDF
(Rus)
Nº 3 (2012)
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Nº 1 (2009)
Cardio-vascular diseases in post-menopause (problems and ways of their solution)
Kirichenko A., Kirichenko A.
Volume 27, Nº 12 (2020)
Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»
Antsiferov M., Galstyan G.
PDF
(Rus)
Nº 15 (2017)
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.
PDF
(Rus)
Nº 19 (2016)
New mechanisms of action of nsaids: focus on cardiovascular safety
Shostak N., Klimenko A., Anichkov D., Kondrashov A.
PDF
(Rus)
Nº 16 (2015)
METABOLIChESKAYa TERAPIYa V PROFILAKTIKE I REABILITATsII BOL'NYKh S KARDIOVASKULYaRNOY PATOLOGIEY: SOVREMENNYE POZITsII TIOTRIAZOLINA
Lyamina N., Nalivaeva A., Kotel'nikova E., Korobkova L.
PDF
(Rus)
Nº 9 (2014)
PREPARATY MAGNIYa V KOMPLEKSNOY TERAPII I PROFILAKTIKE SERDEChNOSOSUDISTYKh ZABOLEVANIY
Mubarakshina O., Somova M.
PDF
(Rus)
Nº 15 (2011)
PLACE OF ASPIRIN IN THE THERAPY OF ATHEROTHROMBOSIS AND ITS COMPLICATIONS
Gilyarov M., Gilyarov M.
Nº 7 (2010)
Psychiatric disturbances in cardiological practice
Artyukhova M., Artuhova M.
Volume 27, Nº 5 (2020)
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
Karoli N., Rebrov A.
PDF
(Rus)
Nº 15 (2017)
Cardiovascular safety and efficacy of celecoxib: focus on treatment and cardiosomatic rehabilitation
Lyamina N., Karpova E.
PDF
(Rus)
Nº 16 (2016)
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A., Sharonova L.
PDF
(Rus)
Nº 15 (2013)
Vozmozhnosti primeneniya beta-adrenoblokatorov v lechenii serdechnososudistykh zabolevaniy u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh
Statsenko M., Derevyanchenko M.
PDF
(Rus)
Nº 15 (2009)
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
Volume 29, Nº 3 (2022)
Drug safety in real clinical practice: focus on protective therapy
Trukhan D., Ivanova D.
PDF
(Rus)
Volume 27, Nº 3 (2020)
Increased intestinal permeability and its role in the development of cardiovascular diseases
Vorobyeva N., Tkacheva O.
PDF
(Rus)
Nº 16 (2016)
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
PDF
(Rus)
Nº 13 (2015)
Otsenka vzaimosvyazi parodontita i serdechno- sosudistykh zabolevaniy
Grudyanov A., Tkacheva O., Avraamova T., Khvatova N.
PDF
(Rus)
Nº 20 (2010)
EFFICACY OF OMEGA-3 POLYUNSATURATED FATTY ACID FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES: CURRENT STATE OF THE PROBLEM
Gilyarevskiy S., Gilyarevsky S.
Nº 15 (2009)
Phytosterins and cardiovascular diseases
Perova N., Perova N.
1 - 57 de 57 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies